Abstracts tagged "Arthrocentesis"

Abstract Number: 2509 • 2012 ACR/ARHP Annual Meeting
Cost-Effectiveness of Training Rural Providers to Perform Joint Injections
Michael J. Battistone¹, Richard E. Nelson², William D. Ashworth³, Andrea Barker³, Marissa Grotzke⁴, Timothy A. Huhtala⁵, Robert Z. Tashjian⁶ and Grant W. Cannon¹, ¹Division of Rheumatology, Salt Lake City VA and University of Utah, Salt Lake City, UT, ²Division of Epidemiology, Salt Lake City VA and University of Utah, Salt Lake City, UT, ³General Internal Medicine, Salt Lake City VA and University of Utah, Salt Lake City, UT, ⁴Division of Endocrinology, Salt Lake City VA and University of Utah, Salt Lake City, UT, ⁵Division of General Internal Medicine, Salt Lake City VA and University of Utah, Salt Lake City, UT, ⁶Division of Orthopaedics, Salt Lake City VA and University of Utah, Salt Lake City, UT
Background/Purpose: Community based outpatient clinics (CBOCs) have been established by the Department of Veteran Affairs (VA) to provide primary care services to veterans living in…
Abstract Number: 2054 • 2012 ACR/ARHP Annual Meeting
Safety of Joint and Soft Tissue Injections in Patients On Warfarin Anti-Coagulation
Richard Conway¹, Finbar (Barry) D. O'Shea², Gaye Cunnane³ and Michele Doran³, ¹Rheumatology, St James's Hospital, Dublin, Ireland, ²Rheumatology Dept, St James's Hospital, Dublin, Ireland, ³Dept of Rheumatology, St James's Hospital, Dublin, Ireland
Background/Purpose: Joint and soft tissue injections are commonly performed in clinical practice. An increasing number of patients are prescribed warfarin. Joint and soft tissue injections…
Abstract Number: 1894 • 2012 ACR/ARHP Annual Meeting
Factors Associated with Confidence Level of Rheumatology Fellows in Joint Procedural Skills
Tara J. Rizvi¹, Min Xu¹ and Nancy Searle², ¹Rheumatology, Baylor College of Medicine, Houston, TX, ²Department of Pediatrics and Medicine, Baylor College of Medicine, Houston, TX
Background/Purpose: Rheumatology fellowship programs in the U.S. lack clear standardized criteria to train fellows in joint procedural skills. More recently, some programs are utilizing joint…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].